How long does cefuroxime take to reduce fever?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Time to Fever Reduction with Cefuroxime

Fever typically begins to decline within 48 to 72 hours after starting cefuroxime therapy for bacterial infections. This timeframe is consistent across multiple bacterial infections including acute otitis media, pneumonia, and other respiratory tract infections.

Expected Clinical Response Timeline

The clinical improvement pattern with cefuroxime follows a predictable course:

  • First 24 hours: Symptoms may initially worsen slightly or remain stable
  • 24-48 hours: Temperature should begin to decline; patients start showing early signs of improvement
  • 48-72 hours: Fever should resolve or significantly improve; this is the critical assessment window 1

If fever persists beyond 72 hours, treatment failure should be considered, prompting reassessment for resistant organisms, complications, or alternative diagnoses 1.

Context-Specific Considerations

Acute Otitis Media

In children with acute otitis media treated with cephalosporins like cefuroxime, clinical improvement (including defervescence) should be noted within 48-72 hours. If initially febrile, temperature should decline within this window, with irritability and fussiness lessening or disappearing 1.

Respiratory Tract Infections

For bacterial respiratory infections, the 48-72 hour window remains the standard for assessing therapeutic response. A 4-day course of cefuroxime axetil showed symptom resolution (including fever) in over 90% of patients with acute maxillary sinusitis and acute otitis media 2.

Pyelonephritis

In women with acute pyelonephritis, the median time to defervescence with cefuroxime was 55 hours (interquartile range 37-70 hours), with defervescence rates of approximately 81% at 72 hours 3.

Important Caveats

Factors that may delay fever resolution include:

  • Bacteremia
  • Extended-spectrum β-lactamase (ESBL)-producing organisms
  • High inflammatory markers (C-reactive protein ≥15 mg/dL)
  • Elevated white blood cell counts (≥15,000/mm³)
  • Concurrent viral infection 3

The 48-72 hour assessment point is critical because it distinguishes between appropriate response and treatment failure, guiding decisions about antibiotic modification or further investigation 1.

For enteric fever specifically, 60% of patients responded within 4 days, and 87% within 7 days of cefuroxime treatment 4, though this represents a different infection pattern than typical respiratory or urinary tract infections.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.